Legend Biotech (LEGN) Other financing activities (2020 - 2025)
Legend Biotech's (LEGN) quarterly Other financing activities came in at $901.9 million in Q4 2025, up 214.58% YoY from $286.7 million in Q4 2024, and up 30073.97% on a QoQ basis from $3.0 million in Q3 2025.
Legend Biotech (LEGN) Other financing activities (2020 - 2025) Analysis & Trends
Legend Biotech (LEGN) has 6 years of Other financing activities data on file, last reported at $901.9 million in Q4 2025.
- Quarterly Other financing activities rose 214.58% year-over-year to $901.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $904.9 million (up 205.9% YoY) and the FY2025 annual result came in at $901.9 million, up 214.58% from the prior year.
- Other financing activities rose to $901.9 million in Q4 2025, from $3.0 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $1.3 billion in Q4 2023 to a low of -$1.7 million in Q2 2024.
- A 5-year average of $181.6 million and a median of $1.3 million in 2022 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 79550.0% in 2024, down 83100.0% in 2024.
- Tracing LEGN's Other financing activities over 5 years: stood at -$1.1 million in 2021, then surged by 74253.87% to $786.0 million in 2022, then jumped by 62.55% to $1.3 billion in 2023, then tumbled by 77.56% to $286.7 million in 2024, then jumped by 214.58% to $901.9 million in 2025.
- The last three Other financing activities figures came in at $901.9 million (Q4 2025), $3.0 million (Q3 2025), and -$1.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Legend Biotech | 3.95 Bn | 3.27 Bn | 251.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 901.90 Mn |
| Dec 31, 2025 | 901.90 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Jun 30, 2025 | -1.44 Mn |
| Jun 30, 2025 | -1.44 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Mar 31, 2025 | 1.44 Mn |
| Dec 31, 2024 | 286.70 Mn |
| Dec 31, 2024 | 286.70 Mn |
| Sep 30, 2024 | 9.18 Mn |
| Sep 30, 2024 | 9.18 Mn |
| Jun 30, 2024 | -1.66 Mn |
| Jun 30, 2024 | -1.66 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Mar 31, 2024 | 1.59 Mn |
| Dec 31, 2023 | 1.28 Bn |
| Dec 31, 2023 | 1.28 Bn |
| Jun 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 2,000.00 |